{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2017-07-19&AnsweringBody.=Home+Office&hansardHeading=Drugs%3A+Misuse", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-answer.dateOfAnswer=2017-07-19&AnsweringBody.=Home+Office&hansardHeading=Drugs%3A+Misuse", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2017-07-19&AnsweringBody.=Home+Office&_metadata=all&hansardHeading=Drugs%3A+Misuse", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2017-07-19&_page=0&AnsweringBody.=Home+Office&hansardHeading=Drugs%3A+Misuse", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2017-07-19&AnsweringBody.=Home+Office&hansardHeading=Drugs%3A+Misuse", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2017-07-19&AnsweringBody.=Home+Office&hansardHeading=Drugs%3A+Misuse", "items" : [{"_about" : "http://data.parliament.uk/resources/1716241", "AnsweringBody" : [{"_value" : "Home Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1716241/answer", "answerText" : {"_value" : "<p>In December 2021, the Government launched its ten-year drugs strategy, to cut crime and save lives<em>. <\/em>As part of this, £300 million has been allocated to fund activity to break drug supply chains from end-to-end, This includes restricting upstream flow, securing the UK border, and ensuring we remain agile in the face of changing threats.<\/p><p>The National Crime Agency (NCA) regularly assess the threat posed to the UK by the trafficking of illicit drugs. At this time, we are not aware of any captagon on UK streets and to date, no instances of captagon being seized at a UK border have been recorded; however, shipments have been seized in Europe.<\/p><p>As such, the UK will continue to seek coordinated global action to address the effects of the captagon trade, in close cooperation with our regional partners.<\/p><p>Beyond this, the UK Government and its law enforcement partners are leveraging our extensive international networks to maximise cooperation with other governments to tackle drug trafficking upstream. This includes identifying and disrupting organised crime groups aiming to exploit the UK, and seizing drugs before and during their journey to the UK.<\/p><p>Additionally, we are also funding Border Force and the NCA to develop and deliver innovative intelligence-led approaches to securing our border which keeps pace with changes to routes and methods used by criminals.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"}
        }
        , "answeringMemberConstituency" : {"_value" : "Croydon South"}
        , "answeringMemberPrinted" : {"_value" : "Chris Philp"}
        , "dateOfAnswer" : {"_value" : "2024-05-14", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-05-14T16:38:18.897Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "1"}
      , "answeringDeptShortName" : {"_value" : "Home Office"}
      , "answeringDeptSortName" : {"_value" : "Home Office"}
      , "date" : {"_value" : "2024-05-07", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Drugs: Misuse"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for the Home Department, whether Captogan has been found in the UK; and whether his Department is taking steps to prevent it becoming available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4805", "label" : {"_value" : "Biography information for Alicia Kearns"}
      }
      , "tablingMemberConstituency" : {"_value" : "Rutland and Melton"}
      , "tablingMemberPrinted" : [{"_value" : "Alicia Kearns"}
      ], "uin" : "25086"}
    , {"_about" : "http://data.parliament.uk/resources/1714163", "AnsweringBody" : [{"_value" : "Home Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1714163/answer", "answerText" : {"_value" : "<p>No recent assessment has been made of the impact of drug consumption rooms, sometimes referred to as overdose prevention centres, on drug users.<\/p><p>The Government does not support drug consumption rooms. We have been clear that we have concerns about the potential for these facilities to condone drug use and to encourage the continued illicit supply of drugs. They will not be introduced in England and Wales.<\/p><p>While the Government remains open to considering any new evidence, the evidence available to date has informed the current policy position.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"}
        }
        , "answeringMemberConstituency" : {"_value" : "Croydon South"}
        , "answeringMemberPrinted" : {"_value" : "Chris Philp"}
        , "dateOfAnswer" : {"_value" : "2024-05-07", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-05-07T13:31:32.377Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "1"}
      , "answeringDeptShortName" : {"_value" : "Home Office"}
      , "answeringDeptSortName" : {"_value" : "Home Office"}
      , "date" : {"_value" : "2024-04-26", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Drugs: Misuse"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for the Home Department, what recent assessment he has made of the potential impact of overdose prevention units on drug users.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"}
      }
      , "tablingMemberConstituency" : {"_value" : "York Central"}
      , "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"}
      ], "uin" : "23900"}
    , {"_about" : "http://data.parliament.uk/resources/1714164", "AnsweringBody" : [{"_value" : "Home Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1714164/answer", "answerText" : {"_value" : "<p>Tackling illicit drugs, including potent synthetic opioids, is a priority for the Government and through our 10 year drugs strategy \u2018From Harm to Hope\u2019 we are taking action to tackle drug supply and reduce demand.<\/p><p>UK agencies are highly alert to the threat from synthetic drugs, including synthetic opioids like fentanyl and nitazenes, as well as synthetic cannabinoids and benzodiazepines. The Home Office, Department for Health and Social Care (DHSC), National Crime Agency (NCA), Border Force and the National Police Chiefs Council are working with local partners to proactively monitor and respond to synthetic opioid related deaths, tracking drug related deaths and other intelligence to ensure a quick response.<\/p><p>We assess that the scale of trafficking of synthetic opioids into the UK remains low. However, nitazenes, a type of synthetic opioid, have been linked to more than 100 deaths in the UK during the last year. The NCA assess that these substances are manufactured in illicit labs in China and have no evidence to suggest they are manufactured in the UK.<\/p><p>Through the cross-Government Synthetic Opioids Taskforce we are taking action and are working to enhance our drug harms surveillance and early warning system to provide monitoring information on the presence and impact of synthetic opioids or other drug threats to inform our response. It will also include data on lab-tested police seizures as well as state-of-the-art monitoring for the presence of synthetic drugs by analysing wastewater.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"}
        }
        , "answeringMemberConstituency" : {"_value" : "Croydon South"}
        , "answeringMemberPrinted" : {"_value" : "Chris Philp"}
        , "dateOfAnswer" : {"_value" : "2024-05-07", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-05-07T13:30:20.807Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "1"}
      , "answeringDeptShortName" : {"_value" : "Home Office"}
      , "answeringDeptSortName" : {"_value" : "Home Office"}
      , "date" : {"_value" : "2024-04-26", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Drugs: Misuse"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for the Home Department, how he measuring is the level of synthetic drugs being (a) manufactured in the UK and (b) trafficked into the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"}
      }
      , "tablingMemberConstituency" : {"_value" : "York Central"}
      , "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"}
      ], "uin" : "23901"}
    , {"_about" : "http://data.parliament.uk/resources/1713942", "AnsweringBody" : [{"_value" : "Home Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1713942/answer", "answerText" : {"_value" : "<p>Tackling Class A drugs, including synthetic opioids, is a priority for the Government and through our 10 year drugs strategy \u2018From Harm to Hope\u2019 we are taking action to tackle drugs supply and reduce demand.<\/p><p>UK agencies are highly alert to the threat from synthetic drugs, including synthetic opioids like fentanyl and nitazenes, as well as synthetic cannabinoids and benzodiazepines. We assess that the scale of trafficking of synthetic opioids into the UK remains low. However, nitazenes, a type of synthetic opioid, have sadly been linked to more than 100 deaths in the UK during the last year, and we are taking action.<\/p><p>The cross-Government Synthetic Opioids Taskforce is working with partners, such as the NCA, the Department for Health and Social Care and the National Police Chiefs Council to deliver an evidence-based response to the risk posed by synthetic opioids, and to implement effective action to stem the demand and supply of these dangerous substances.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"}
        }
        , "answeringMemberConstituency" : {"_value" : "Croydon South"}
        , "answeringMemberPrinted" : {"_value" : "Chris Philp"}
        , "dateOfAnswer" : {"_value" : "2024-05-02", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-05-02T15:55:34.363Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "1"}
      , "answeringDeptShortName" : {"_value" : "Home Office"}
      , "answeringDeptSortName" : {"_value" : "Home Office"}
      , "date" : {"_value" : "2024-04-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Drugs: Misuse"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for the Home Department, what assessment he has made of trends in the levels of synthetic drugs in circulation.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"}
      }
      , "tablingMemberConstituency" : {"_value" : "York Central"}
      , "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"}
      ], "uin" : "23765"}
    , {"_about" : "http://data.parliament.uk/resources/1691176", "AnsweringBody" : [{"_value" : "Home Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1691176/answer", "answerText" : {"_value" : "<p>The Government has not made a formal assessment of the benefits of drug checking facilities, but it recognises the potential harm reduction benefits of them.<\/p><p>The Government facilitates drug checking facilities provided that the possession and supply of controlled drugs are licensed by the Home Office Drugs and Firearms Licensing Unit or, exceptionally, relevant exemptions under the Misuse of Drugs Regulations 2001 may apply.<\/p><p>Ministers are clear that drug checking services must not condone drug use and should only be delivered where licensed and operated responsibly, in line with Government policy to ensure that they discourage drug use and signpost potential users to treatment and support.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"}
        }
        , "answeringMemberConstituency" : {"_value" : "Croydon South"}
        , "answeringMemberPrinted" : {"_value" : "Chris Philp"}
        , "dateOfAnswer" : {"_value" : "2024-02-29", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-02-29T11:56:51.273Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "1"}
      , "answeringDeptShortName" : {"_value" : "Home Office"}
      , "answeringDeptSortName" : {"_value" : "Home Office"}
      , "date" : {"_value" : "2024-02-22", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Drugs: Misuse"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for the Home Department, if he will make an assessment of the potential merits introducing drug contamination testing facilities in (a) England and (b) Romford constituency.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1447", "label" : {"_value" : "Biography information for Andrew Rosindell"}
      }
      , "tablingMemberConstituency" : {"_value" : "Romford"}
      , "tablingMemberPrinted" : [{"_value" : "Andrew Rosindell"}
      ], "uin" : "15240"}
    , {"_about" : "http://data.parliament.uk/resources/1680755", "AnsweringBody" : [{"_value" : "Home Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1680755/answer", "answerText" : {"_value" : "<p>The term \u2018harm reduction units for the use of drug taking in a safe environment\u2019 refers to what are often more commonly known as Drug Consumption Rooms (DCRs).<\/p><p>The Government does not support DCRs. We have been clear that we have concerns about the potential for these facilities to appear to condone drug use and to encourage the continued illicit supply of drugs. They will not be introduced in England and Wales. While we remain open to considering any new evidence, the evidence available to date has informed the current policy position.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"}
        }
        , "answeringMemberConstituency" : {"_value" : "Croydon South"}
        , "answeringMemberPrinted" : {"_value" : "Chris Philp"}
        , "dateOfAnswer" : {"_value" : "2024-01-16", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-01-16T17:42:26.383Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "1"}
      , "answeringDeptShortName" : {"_value" : "Home Office"}
      , "answeringDeptSortName" : {"_value" : "Home Office"}
      , "date" : {"_value" : "2024-01-09", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Drugs: Misuse"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for the Home Department, if he will make an assessment of the potential merits of harm reduction units for the use of drug taking in a safe environment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"}
      }
      , "tablingMemberConstituency" : {"_value" : "York Central"}
      , "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"}
      ], "uin" : "8775"}
    , {"_about" : "http://data.parliament.uk/resources/1678712", "AnsweringBody" : [{"_value" : "Home Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1678712/answer", "answerText" : {"_value" : "<p>As set out by the response to Written Answer HL767, the Advisory Council on the Misuse of Drugs (ACMD) marked the document titled \u201cInteraction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016\u201d \u201cin confidence\u201d. The document was not intended for publication and there are no plans to publish it. The portion that has been made public was made public under the terms of the Freedom of Information Act 2000 (\u201cFOIA 2000\u201d) and following the decision of the relevant tribunal (case reference EA/2021/0301).<\/p><p> <\/p><p>The portion released under the FOIA 2000 recommended a review of the Working Protocol between the ACMD and the Home Office to take into account the functions of the ACMD under the Psychoactive Substances Act 2016 (\u201cthe 2016 Act\u201d). The Working Protocol has not been revised since 2011 and is available at the following link: <a href=\"https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fworking-protocol-between-the-home-secretary-and-the-advisory-council-on-the-misuse-of-drugs&amp;data=05%7C02%7CLiam.Price2%40homeoffice.gov.uk%7C0f3b5e5094924fd41a1f08dc007d513b%7Cf24d93ecb2914192a08af182245945c2%7C0%7C0%7C638385785729643796%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=XnT9RCvi7TX1aQJ07uHM7aufQZsu5b94e9Vwc0EZ1H4%3D&amp;reserved=0\" target=\"_blank\">Working Protocol between the Home Secretary and the Advisory Council on the Misuse of Drugs - GOV.UK (www.gov.uk)<\/a><\/p><p> <\/p><p>The Government intends to undertake a review in due course and if this results in a revised Working Protocol, the revised version will be published on gov.uk.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4888", "label" : {"_value" : "Biography information for Lord Sharpe of Epsom"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Sharpe of Epsom"}
        , "dateOfAnswer" : {"_value" : "2023-12-20", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "HL1279"}
        , {"_value" : "HL1280"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-12-20T16:45:20.61Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "1"}
      , "answeringDeptShortName" : {"_value" : "Home Office"}
      , "answeringDeptSortName" : {"_value" : "Home Office"}
      , "date" : {"_value" : "2023-12-18", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Drugs: Misuse"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government, further to the Written Answer by Lord Sharpe of Epsom on 14 December (HL767), on what basis the Advisory Council for the Misuse of Drugs report Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016, sent to the Home Secretary in December 2016, was shared \"in confidence\"; and who took the decision to waive any such confidentiality in relation to the part of the report that has been made public.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4297", "label" : {"_value" : "Biography information for Baroness Jones of Moulsecoomb"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Jones of Moulsecoomb"}
      ], "uin" : "HL1278"}
    , {"_about" : "http://data.parliament.uk/resources/1678713", "AnsweringBody" : [{"_value" : "Home Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1678713/answer", "answerText" : {"_value" : "<p>As set out by the response to Written Answer HL767, the Advisory Council on the Misuse of Drugs (ACMD) marked the document titled \u201cInteraction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016\u201d \u201cin confidence\u201d. The document was not intended for publication and there are no plans to publish it. The portion that has been made public was made public under the terms of the Freedom of Information Act 2000 (\u201cFOIA 2000\u201d) and following the decision of the relevant tribunal (case reference EA/2021/0301).<\/p><p> <\/p><p>The portion released under the FOIA 2000 recommended a review of the Working Protocol between the ACMD and the Home Office to take into account the functions of the ACMD under the Psychoactive Substances Act 2016 (\u201cthe 2016 Act\u201d). The Working Protocol has not been revised since 2011 and is available at the following link: <a href=\"https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fworking-protocol-between-the-home-secretary-and-the-advisory-council-on-the-misuse-of-drugs&amp;data=05%7C02%7CLiam.Price2%40homeoffice.gov.uk%7C0f3b5e5094924fd41a1f08dc007d513b%7Cf24d93ecb2914192a08af182245945c2%7C0%7C0%7C638385785729643796%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=XnT9RCvi7TX1aQJ07uHM7aufQZsu5b94e9Vwc0EZ1H4%3D&amp;reserved=0\" target=\"_blank\">Working Protocol between the Home Secretary and the Advisory Council on the Misuse of Drugs - GOV.UK (www.gov.uk)<\/a><\/p><p> <\/p><p>The Government intends to undertake a review in due course and if this results in a revised Working Protocol, the revised version will be published on gov.uk.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4888", "label" : {"_value" : "Biography information for Lord Sharpe of Epsom"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Sharpe of Epsom"}
        , "dateOfAnswer" : {"_value" : "2023-12-20", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "HL1278"}
        , {"_value" : "HL1280"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-12-20T16:45:20.67Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "1"}
      , "answeringDeptShortName" : {"_value" : "Home Office"}
      , "answeringDeptSortName" : {"_value" : "Home Office"}
      , "date" : {"_value" : "2023-12-18", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Drugs: Misuse"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government, further to the Written Answer by Lord Sharpe of Epsom on 14 December (HL767), what steps they have taken to ensure that parliamentarians are properly informed about the issues raised in the Advisory Council for the Misuse of Drugs report Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016, sent to the Home Secretary in December 2016.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4297", "label" : {"_value" : "Biography information for Baroness Jones of Moulsecoomb"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Jones of Moulsecoomb"}
      ], "uin" : "HL1279"}
    , {"_about" : "http://data.parliament.uk/resources/1678715", "AnsweringBody" : [{"_value" : "Home Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1678715/answer", "answerText" : {"_value" : "<p>The Government does not support drug consumption rooms. We have been clear that we have concerns about the potential for these facilities to appear to condone drug use and to encourage the continued illicit supply of drugs. They will not be introduced in England and Wales.<\/p><p> <\/p><p>We are aware of previous international studies of DCRs, sometimes referred to as overdose prevention centres, although there is usually little or no focus on how far DCRs reduce illicit drug use by those using DCRs, or whether they result in reductions in overall drug use. Methodological and geographical differences as well as the small number of cities where DCRs operate makes it difficult to draw firm conclusions at this stage. In addition, the impact of DCRs in isolation is hard to measure as a range of other support and interventions such as needle and syringe exchange programmes are often provided within a DCR.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4888", "label" : {"_value" : "Biography information for Lord Sharpe of Epsom"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Sharpe of Epsom"}
        , "dateOfAnswer" : {"_value" : "2024-01-11", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-01-11T14:21:25.97Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "1"}
      , "answeringDeptShortName" : {"_value" : "Home Office"}
      , "answeringDeptSortName" : {"_value" : "Home Office"}
      , "date" : {"_value" : "2023-12-18", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Drugs: Misuse"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government what assessment they made of the effectiveness of overdose prevention centres in reducing death and other harms caused by drug use to individuals and society; and why they do not support pilot overdose prevention centres.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4297", "label" : {"_value" : "Biography information for Baroness Jones of Moulsecoomb"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Jones of Moulsecoomb"}
      ], "uin" : "HL1281"}
    , {"_about" : "http://data.parliament.uk/resources/1675121", "AnsweringBody" : [{"_value" : "Home Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1675121/answer", "answerText" : {"_value" : "<p>BlueLight Commercial is company that is owned by the policing sector. It was set up to provide commercial expertise and assistance to policing and assist forces in identifying and making efficiency savings.<\/p><p>The Government have not provided specific funding to BlueLight Commercial for their work on Operation Safeguard. BlueLight Commercial have direct arrangements with the policing sector to cover administrative costs they have incurred for the work they have delivered.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"}
        }
        , "answeringMemberConstituency" : {"_value" : "Croydon South"}
        , "answeringMemberPrinted" : {"_value" : "Chris Philp"}
        , "dateOfAnswer" : {"_value" : "2023-12-12", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-12-12T12:48:43.133Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "1"}
      , "answeringDeptShortName" : {"_value" : "Home Office"}
      , "answeringDeptSortName" : {"_value" : "Home Office"}
      , "date" : {"_value" : "2023-12-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Drugs: Misuse"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for the Home Department, how much funding was provided to Blue Blight Commercial as part of Operation Safeguard.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4389", "label" : {"_value" : "Biography information for Ruth Cadbury"}
      }
      , "tablingMemberConstituency" : {"_value" : "Brentford and Isleworth"}
      , "tablingMemberPrinted" : [{"_value" : "Ruth Cadbury"}
      ], "uin" : "5061"}
    ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2017-07-19&_page=1&AnsweringBody.=Home+Office&hansardHeading=Drugs%3A+Misuse", "page" : 0, "startIndex" : 1, "totalResults" : 109, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}